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’ INTRODUCTION
At least nine human diseases are associated with mutations
that extend the length of a polyQ-encoding CAG repeat in a
corresponding disease protein.1 Since neurons in brain tissue
from these diseases exhibit polyQ-rich aggregates,2 and since polyQ
peptides in vivo3 and in vitro4,5 exhibit repeat length dependent
aggregation kinetics, there is considerable interest in the role of
protein aggregation in the disease mechanisms. The only com-
mon element in these disease proteins, the expanded polyQ
sequence, in isolation aggregates by a nucleated growth mechan-
ism without any nonamyloid intermediates.6-8 While some
polyQ ﬂanking sequences do not alter this fundamental
mechanism,9-11 in other cases the ﬂanking sequence can play a
dramatic role by kinetically overriding the normal polyQ nuclea-
tion mechanism.10,12,13 The nature of the ﬂanking sequences also
has direct consequences for the aggregate morphology and
observed toxicity.14-16 In the protein huntingtin (htt), which is
responsible for Huntington’s disease (HD), a short and moderately
hydrophobic 17 amino acidN-terminal sequence (httNT) ﬂanking the
polyQ sequence plays an enormous role in stimulating aggregation
and altering the aggregation mechanism.10,17,18 In N-terminal frag-
ments similar to the likely toxic proteolysis products19 of the htt
protein, the httNT sequence dramatically enhances aggregation
rates in vivo20 and in vitro,10,17 apparently by mediating the rapid
formation of spherical oligomers with the httNT segment at their
core.10 Interestingly, most other protein sequences that form
amyloids also appear to spontaneously assemble in vitro via the
intermediate formation of similar oligomeric structures.21-23
Understanding this mechanism and its products in greater detail
may reveal new approaches for intervention in aggregate formation
in HD and other disorders. In spite of several experimental10,17,18
and computational24,25 studies, much remains to be learned.
Central questions include the structural transformations from
monomer to oligomer to ﬁbril for each of the separate domain
segments and how these domains might interact to further aﬀect
the mechanism and rate. Fibrils formed by polyQ peptides without
ﬂanking domains are known to consist of β-sheet structure,26,27
analogous to other amyloids. The mechanisms by which ﬂanking
sequences can modulate polyQ aggregation mechanisms and/or
rates are varied. A polyPro segment C-terminal to polyQ slows
aggregation, apparently by altering the distribution of various
polyQ conformations in the low molecular weight, soluble
ensemble.9,28,29 In several other cases, the ﬂanking sequence instead
aids or initiates polyQ aggregation by virtue of its own propensity
for amyloid formation. In the disease protein ataxin-3 (AT-3), the
large Josephin domain initiates aggregation by forming an amyloid
structure itself, which then directly or indirectly propagates into the
polyQ segment.12 Similarly, in an artiﬁcial polyQ protein formed by
fusion of polyQ to cellular retinoic acid binding protein (CRABP),
Received: November 29, 2010
ABSTRACT: The 17-residue N-terminus (httNT) directly ﬂank-
ing the polyQ sequence in huntingtin (htt) N-terminal frag-
ments plays a crucial role in initiating and accelerating the
aggregation process that is associated with Huntington’s disease
pathogenesis. Here we report on magic-angle-spinning solid-
state NMR studies of the amyloid-like aggregates of an htt
N-terminal fragment. We ﬁnd that the polyQ portion of this
peptide exists in a rigid, dehydrated amyloid core that is
structurally similar to simpler polyQ ﬁbrils and may contain antiparallel β-sheets. In contrast, the httNT sequence in the aggregates
is composed in part of a well-deﬁned helix, which likely also exists in early oligomeric aggregates. Further NMR experiments
demonstrate that the N-terminal helical segment displays increased dynamics and water exposure. Given its speciﬁc contribution to
the initiation, rate, and mechanism of ﬁbril formation, the helical nature of httNT and its apparent lack of eﬀect on the polyQ ﬁbril
core structure seem surprising. The results provide new details about these disease-associated aggregates and also provide a clear
example of an amino acid sequence that greatly enhances the rate of amyloid formation while itself not taking part in the amyloid
structure. There is an interesting mechanistic analogy to recent reports pointing out the early-stage contributions of transient
intermolecular helix-helix interactions in the aggregation behavior of various other amyloid ﬁbrils.
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CRABPaggregates ﬁrst, followed by polyQ amyloid formation.30 In
both cases, the Josephin and CRABP domains alone have an
independent folded conformation, but are capable of aggregating
into amyloid ﬁbrils under appropriate conditions.
As an aggregation-assisting domain, the httNT segment has
some interesting diﬀerences from these two cases, in terms of
both its innate structure and its ability to form an amyloid in
isolation. The httNT sequence by itself exhibits tediously slow
aggregation kinetics10 and, on aggregation, forms oligomeric
structures, similar to the intermediates of htt N-terminal frag-
ment aggregation, but fails to progress to amyloid structures. In
terms of its structure, simulations31 and structure-propensity
calculations17 predict httNT to exist in anR-helical conformation,
but a sequence-based analysis of the intrinsic structure indicates
only a modest tendency toward order.10 Experimentally, mono-
meric httNT exhibits no stable secondary structure by solution
NMR,10 but displays a degree of R-helicity in CD spectra.10,16,25
There is little direct information on the structural transforma-
tions undergone by httNT during amyloid formation by httNT-
containing polyQ sequences. Mutations within httNT designed to
diminish R-helical propensity diminish the aggregation of htt
exon1 mutants17 as well as some httNT targeting functions in the
cell.16 Independent of its initial conformation, it would be
reasonable to expect that httNT might become incorporated into
the β-stranded amyloid structure along with the polyQ elements.
Thus, this is consistent with observations of transformations of
native structure to amyloid β-structure (e.g., seen in the Josephin
and CRABP domains, as well as other proteins32). This expecta-
tion is also in line with simulations suggesting a conversion of R-
to β-structure within httNT as a result of, or even a prerequisite
for, amyloid formation.24 Experimental data that seem consistent
with a transition into β-structure include ﬂuorescence data
indicating that residues 11 and 17 within httNT in httNT-polyQ
peptides become much more solvent-excluded as oligomers
transition into amyloid ﬁbrils.10
On the basis of the use of magic-angle-spinning (MAS) solid-
state (ss) NMR techniques33 augmented by FTIR and electron
microscopy (EM), we report here on the structure of ﬁbrillar
aggregates formed by the htt N-terminal fragment httNTQ30P10K2
(Figure 1). Incorporation of 13C,15N-labels into residues within
the N-terminal segment of this construct permitted site-speciﬁc
characterization of residues within both the httNT and polyQ
domains. This revealed a β-sheet structure for polyQ residues and
for residues at the httNT-polyQ boundary, with spectroscopic
signatures for the former that indicated a strong resemblance to
glutamines in simple polyQ peptide ﬁbrils. Surprisingly, our data
also clearly indicated an R-helical segment in the N-terminal
portion of the httNT sequence, which shows increased mobility
and exposure to water compared to the rigid β-sheet core of the
ﬁbrils. FTIR suggests that a helical conformation is also likely the
dominant secondary structural feature of the initially formed httNT
oligomers. Thus, our data suggest that the httNT sequence exerts
its dramatic ability to enhance the rate of formation of β-rich
amyloid ﬁbrils without either relinquishing its own initial R-helical
structure or greatly inﬂuencing the β-sheet structure in the polyQ-
rich core of the ﬁbril.
’MATERIALS AND METHODS
Synthesis and Fibril Formation. Fmoc-protected 13C- and/or
15N-labeled amino acids were from Cambridge Isotope Laboratories
(Andover, MA) and Isotec (Sigma-Aldrich, St. Louis, MO). Site-specifi-
cally labeled peptides were prepared by solid-phase peptide synthesis by
the W.M. Keck Facility at Yale University (see also Table S2 in the
Supporting Information). Crude peptide was purified in-house, disaggre-
gated and fibrillized as described previously.10,34 Briefly, fibril formation
took place in PBS buffer at 37 C and was monitored via HPLC-based
sedimentation assays. Themorphology of themature fibrils was examined
via transmission electron microscopy (TEM), using an FEI Tecnai 12
electron microscope (Hillsboro, OR), employing negative staining with
1% uranyl acetate.
Fourier Transform Infrared Spectroscopy.Mature aggregated
samples were studied by FTIR, using methods analogous to those
described previously.10 The FTIR samples were prepared by resuspen-
sion into 3 μL of PBS of a pellet obtained by centrifugation at 20817g for
45 min. The pelleted material was characterized using an MB series
spectrophotometer (ABB Bomem, Quebec City, QC, Canada) and PROTA
software from Biotools Inc. (Jupiter, FL). The FTIR data are reported as
second-derivative spectra as calculated using the PROTA software.
Magic-Angle-Spinning Solid-State NMR Spectroscopy.
After being washed with 10 mM sodium phosphate buffer, the mature
fibrils were packed into MAS rotors (Bruker Biospin, Billerica, MA) by
centrifugation, keeping them hydrated and unfrozen at all times. Unless
indicated otherwise, NMR experiments were performed using a wide-
bore Bruker Avance I spectrometer operating at a 600 MHz 1H Larmor
frequency (14.3 T) using Bruker 3.2mmMAS EFree HCN probes. Some
data were acquired on an Avance II spectrometer with an 800 MHz 1H
Larmor frequency (19 T). The sample temperature was controlled with
cooled gas, while avoiding freezing of the samples. 2D 13C-13C
experiments relied on 1H-13C cross-polarization (CP) followed by
dipolar-assisted rotational resonanace(DARR) mixing35 for the 13C-13C
Figure 1. Aggregation kinetics and peptide sequences. Aggregation kinetics were followed by an HPLC-based sedimentation assay, starting from
disaggregated monomeric peptide. Labeled (open symbols) and unlabeled (gray circles, R2 = 0.9912, SD =(3.59) httNTQ30P10K2 (at∼10 μM) show
accelerated aggregation relative to peptide lacking httNT, e.g., 10 μMK2Q31K2 (black triangles, R
2 = 0.9909, SD =(4.02) or K2Q30K2 (with [13C,15N-
Gln6]; black tilted squares, R2 = 0.9926, SD =(3.16). Note the qualitative diﬀerence in the initial rate regime. By itself, 10 μMhttNT (black squares,R2 =
0.9534, SD = (1.5169) shows only a limited amount of aggregation.
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transfers, with mixing times between 8 and 100 ms and 83-100 kHz two
pulse phase modulation (TPPM) 1H decoupling36 during acquisition and
evolution. Additional 13C single-quantum (SQ)-double-quantum (DQ)
2D experiments at 12 kHz MAS and ω0,H/2π = 600 MHz employed
super-cycled POST-CS (SPC53) to generate DQ coherence.
37 Inter-
residue distancemeasurements in sample p4 (httNTQ30P10K2 labeledwith
13C0-Leu7, 13Cβ-Ala10, and 13C0-Phe17) were performed at 600 MHz
(1H frequency) using a 4 mm Bruker MAS HCN solenoid probe,
employing proton-driven spin diffusion (PDSD) 13C-13C recoupling.
Water-filtered 1H-13C CP experiments that eliminate rigid 1H signals via
a T2 relaxation filter and incorporate a
1H-1H spin diffusion period were
performed analogously to previously published methods (see also Figure
S5 in the Supporting Information).38,39 Spectra were processed and
analyzed with the aid of the NMRPipe, Sparky, and CCPNMR/Analysis
programs.40-42 Indirect external referencing of the 13C shifts relative to
aqueous sodium-3-(trimethylsilyl)propanesulfonate(DSS) was done on the
basis of the 13C shifts of adamantane.43 Secondary shift calculations involved
subtraction of random coil shifts reported by Zhang et al.44 Additional
experimental details are listed in Table S3 in the Supporting Information.
’RESULTS
Aggregation Kinetics and Morphology. Consistent with
previous results, the presence of the httNT segment in the
httNTQ30P10K2 construct strongly enhances its rate of aggregation
compared to that of polyQmodel peptides of an equivalent length
(Figure 1). TEM shows that the morphology of the
httNTQ30P10K2 fibrils is similar to that of fibrils formed by
analogous constructs with different polyQ lengths,10 but appears
to differ from that of the polyQ peptide fibrils (Figure 2). The
polyQ peptides form ribbon-like fibrils of variable widths, whereas
the fibrils formed by httNTQ30P10K2 are more well-defined. As
noted previously,10 the httNT segment itself is much less prone to
aggregate, but does form a limited amount of an oligomeric
aggregate, as shown in Figures 1 and 2. The morphology of
these httNT aggregates resembles that of the characteristic oligo-
meric intermediates observed early in the aggregation of
httNTQ30P10K2 and other amyloid fibrils. As expected, the in-
corporation of 13C- and 15N-labeled residues in various peptides
does not noticeably affect the fibril morphology or aggregation
kinetics (Figure 1; compare open symbols and gray circles), even
without seeding with pre-existing aggregates.
Secondary Structure Analysis of Aggregates by FTIR. The
secondary structure content of the aggregated peptides was
examined by FTIR spectroscopy. The results (Figure 2) show
that the oligomeric aggregates formed by the isolated httNT
peptide are predominantlyR-helical in structure. Note that this is
in contrast to the behavior of the monomeric peptide, which was
previously found to be largely unstructured by solution NMR.10
It is well-known that simple polyQmodel peptides aggregate into
β-sheet-rich fibrillar aggregates.26,47 Amide I FTIR data on the
K2Q31K2 fibrils are consistent with this, showing strong bands
characteristic of β-sheet structure46 as well as bending and
stretching modes associated with the glutamine side chain.48
The FTIR spectrum of the httNTQ30P10K2 fibrils is dominated by
the same bands, as previously reported for related constructs.10
Unfortunately, a complete overlap of the R-helix and glutamine
side chain bands of the amide I, as well as the limited ability of
FTIR to give segment specific information, prevents us from
extracting information on the secondary structure of httNT in
these aggregates. Keeping in mind this ambiguity about the
structure of the httNT segment in the fibrils and the limited
resolution of the technique, our FTIR data are unable to show
any structural difference between httNTQ30P10K2 and K2Q31K2
fibrils (even in the respective polyQ domains).
ssNMR Chemical Shift Assignment. To obtain the required
site-specific structural information, we applied MAS ssNMR to
study fibrils prepared from three differently labeled peptides,
featuring U-13C,15N-labeled residues in selected positions (refer
to Table S2 in the Supporting Information): Ala2, Leu7, and
Phe17 (sample p1); Ala10, Phe11, Leu14, and Gln18 (sample
p2); Leu4, Lys6, Ser16, and Gln19 (sample p3). 2D 13C-13C
DARR experiments35 were primarily used to assign the 13C
resonances (Table S1 in the Supporting Information). Repre-
sentative 2D spectra with a 25 ms mixing time are shown in
Figure 3. We observed single resonances for many of the labeled
sites (Ala2, Leu4, Lys6, Leu7, Ala10, Phe11, Leu14). However,
for several sites multiple signals were observed, most noticeably
for the labeled glutamines at positions 18 and 19. The 2D DARR
spectra show twice the cross-peaks expected for a singly labeled
glutamine, as highlighted in Figure 4a,b. Intriguingly, these
doubled sets of resonances are nearly identical between Gln18
and Gln19. These observations indicate that both residues
feature two distinct conformations with approximately equal
intensity. In addition, within each conformer the chemical shifts
of the glutamine Cβ and Cγ appear nearly identical. As these
shift patterns are somewhat unusual, we obtained further evi-
dence for this from 2D spectra that correlate SQ and DQ
frequencies, employing SPC53 DQ mixing
37 (e.g., Figure 4d).
Such spectra lack diagonal peaks (including the signals due to
Figure 2. Aggregate morphology and secondary structure. Negatively
stained transmission electron micrographs (left) and second-derivative
FTIR data (right) of (a, d) httNT peptide aggregates, (b, e) mature ﬁbrils
formed by the polyQmodel peptide K2Q31K2, and (c, f) htt
NTQ30P10K2.
The TEM scale bars indicate a length of 50 nm. The httNT FTIR
spectrum indicates substantial R-helical content, whereas that of the
polyQ ﬁbrils is dominated by the Gln signals and indicates β-sheet
secondary structure.10 Despite morphological diﬀerences by TEM, the
httNTQ30P10K2 FTIR data strongly resemble the polyQ results. No
helical signals can be unequivocally identiﬁed due to the overlap between
the Gln signals and the helical band. Band assignments: (d) 1655 cm-1,
R-helix; (e, f) 1657 cm-1, Gln side chain CdO stretch; 1626 cm-1,
β-sheet; 1605 cm-1, Gln side chain NH2 deformation.
45,46.
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natural abundance 13C sites), facilitating the identification of
cross-peaks between nuclei with (nearly) identical shifts. Gen-
erally one expects pairs of peaks that bracket a pseudodiagonal
(shown in gray), reflecting directly bonded pairs of sites. If both
carbons have identical frequencies, they show up as a single peak
on this line, and we indeed observe this for the Gln19 Cβ and Cγ
resonances of both forms. Analogous data were obtained for
Gln18 (not shown). In addition to the doubling of the glutamine
signals, we also observe doubling in Ser16 and Phe17, with the
former being clearly visible in Figure 4d. Note that we currently
lack the data to know how the two forms for these sequential
“doubled” residues (marked “a” and “b” in the figures) correlate
with each other.
Secondary Structure Identification. The observed chemical
shifts were used to identify the secondary structure of the labeled
residues via an approach that compares the shifts to those of the
amino acids in defined secondary structures.49 Figure 5 shows a
graphical representation of the secondary shifts of the labeled
residues, calculated through subtraction of random coil chemical
shifts,44 along with a schematic showing how the secondary
structure elementsmap onto the primary structure. Illustration of
the consensus chemical shift index (CSI) and the CR-Cβ
chemical shift differences (which are insensitive to referencing
differences) can be found in the Supporting Information (Figure
S1). Residues 4, 6, 7, 10, and 11 are R-helical in structure. This is
indicative of an amphipathic helix, as illustrated in Figure 5b.
Residues 16-19 are predominantly in a β-sheet conformation,
with one exception in that one of the two Ser16 forms is neither
clearly β-sheet nor clearly R-helical. Residues Ala2 and Leu14
also lack a defined secondary structure, thereby delimiting the
length of the helical segment within the httNT domain. Our
identification of the helix was further supported by the observation
of an inter-residue (if iþ 3) contact consistent with a helical rather
than β-sheet conformation. A 2D 13C-13C PDSD experiment on a
sample (p4) specifically labeled in the 13Cβ of Ala10 and 13C0 of
Leu7 yielded a cross-peak that is indicative of a distance of no
more than 6 Å, consistent with the presence of these two residues
within an R-helix (Figure S2, Supporting Information). We also
tentatively identified the background 13C signals due to the
unlabeled prolines in the polyPro segment and found them to be
similar to those reported for a popyproline II (PPII) helical
conformation50 (see Figure S3, Supporting Information).
Polyglutamine Structure and Mobility. Given the striking
similarity between the Gln18 and Gln19 conformations, we also
probed the signals of a polyQ domain in fibrils of a polyQ peptide
(K2Q30K2) that was labeled in position Gln6 (i.e., the fourth
glutamine). The NMR signals of this residue, which was chosen
to avoid putative hairpin turns,51 showed doubling and chemical
shifts that matched the data for Gln19 of httNTQ30P10K2 fibrils
(Figure 4). To investigate whether these site-specific data reflect
the polyQ domains as a whole, we also examined fully unlabeled
fibrils of a K2Q31K2 and htt
NTQ30P10K2 fibrils. In the absence of
Figure 3. 2D 13C-13C ssNMR spectra using 25 ms DARR mixing, providing 1-2 bond transfers. Measurements on samples p1-p3 are shown in
(a)-(c), with (a) obtained at an 800 MHz 1H frequency and 16 kHz MAS and (b) and (c) at a 600 MHz 1H frequency and 10 and 13 kHz MAS,
respectively. Spinning side bands are marked with asterisks. For each spectrum aliphatic-to-carbonyl (left) and intra-aliphatic (right) spectral regions
are shown.
Figure 4. Doubling and similarity of glutamine resonances. (a, b) 2D 13C-13C DARR spectral regions highlighting the Gln18 and Gln19 resonances in
httNTQ30P10K2 samples p2 and p3. For each residue we observe two distinct sets of resonances, marked as “a” (red) and “b” (blue). The cross-peak
patterns suggest nearly identical chemical shifts for the Cβ and Cγ sites in each case. (c) shows the virtually identical chemical shifts of a singly labeled
glutamine within K2Q30K2 ﬁbrils (U-
13C,15N-Gln6, the fourth residue within polyQ). (d) 2D 13C-13C SQ-DQ spectrum for sample p3 (using 1.5 ms
SPC53 mixing at 12 kHzMAS andω0,H/2π = 600MHz), showing analogously color-coded Gln19 cross-peaks. Doubling appears speciﬁc to the β-sheet
structure: singular sets of resonances are observed for helical residues (e.g., Leu4); doubling can also be seen for Ser16.
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labeling, site-specific assignment is difficult, but the observed
natural abundance 13C signals in the 1D spectrum of K2Q31K2
(Figure 6a) are expected to predominantly represent a summa-
tion of all its combined glutamine signals. Interpretation of the
httNTQ30P10K2 spectrum is not so straightforward, since it also
includes numerous signals from the httNT and polyPro domains
(Figure 6b). Fortunately, however, simple NMR experiments
allow us to distinguish sites on the basis of mobility differences.
These measurements take advantage of the sensitivity of ssNMR
experiments to local dynamics by comparing the observation of
13C magnetization in direct polarization (DP) experiments with
signals obtained by 1H-13C CP. In a DP experiment with short
interscan times, the signal of rigid 13C sites is attenuated due to
their slow relaxation. In contrast, 1H-13C CP experiments
disfavor mobile sites since the 1H to 13C transfer relies on the
dipolar interaction, which is attenuated by dynamics. Indeed,
in the K2Q31K2 fibrils, most signals are eliminated in the DP
spectrum, indicating an overall rigidity of the polyQ amyloid
fibrils. In contrast, many resonances in the httNTQ30P10K2 fibrils
show up strongly in the DP spectrum and are therefore much
more mobile. Application of analogous experiments to the
labeled peptides confirmed that these mobile sites are the non-
Figure 6. PolyQ amyloid core and the eﬀect of the httNT domain. (a) 1H-13CCP (top) and 13CDP (bottom) of unlabeled K2Q31K2 ﬁbrils. These rigid
sites are largely absent from the DP spectrum due to the short recycle delay (3 s). (b) Analogous spectra for unlabeled httNTQ30P10K2 ﬁbrils indicating
increased mobility in many sites. (c) Subtraction of mobile sites in the DP spectrum for httNTQ30P10K2 from its CP spectrum (third row) reveals
the most rigid sites in this sample (bottom). These sites match the pattern of rigid polyQ signals in unlabeled K2Q31K2 ﬁbrils (second row), as well
as the signal from the singly labeled Gln6 in K2Q30K2 (top), which is virtually identical to Gln19 in the htt
NTQ30P10K2 ﬁbril core (Figure 4). Thus,
the site-speciﬁcally labeled glutamine resonances are seemingly unaﬀected by the presence of httNT and appear to be representative of the bulk of
the glutamines in both httNTQ30P10K2 and simple polyQ ﬁbrils.
Figure 5. Site-speciﬁc secondary structure assignment of httNTQ30P10K2 ﬁbrils. (a) Overview of secondary shifts (Δδ) of the labeled C0, CR, and Cβ
sites, revealing helicity (blue) in residues spanning positions 4-11, whereas β-sheet structure (red) is seen in residues 16-19. Residues 2 and 14 match
neither β-sheet nor R-helical conformations (black). Asterisks mark unobserved labeled sites. Bars are split for sites where two conformations were
detected (on the basis of doubled chemical shifts). (b) Schematic representation of observed secondary structure alongside the primary sequence (top),
with the labeled residues in bold and color-coded as in (a). Bottom: helical wheel view of the helical segment (the observed helicity spans the residues in
gray) and a schematic illustration of the amphipathic helix, showing the distribution of hydrophobic residues (front and down) and charged residues
(upward) with arbitrary side chain conformations (prepared using PyMOL, Schr€odinger, LLC). The blue dashed line indicates the observed inter-
residue contact between Ala10-Cβ and Leu7-CO (Figure S2, Supporting Information).
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β-sheet httNT residues, while the glutamine resonances are
effectively “filtered” out of the DP spectrum (see Figure S4,
Supporting Information).
Another way to highlight the most rigid sites is by simply
subtracting the DP (mobile) signals from the CP spectrum.
Applying this approach to the httNTQ30P10K2 ﬁbrils yields a
very speciﬁc set of resonances that strongly resemble not only
the K2Q31K2 ﬁbrils but also the peak positions and characteristic
doubling of the labeled glutamine residues (Figure 6c). This
indicates a strong resemblance between the molecular confor-
mations of the polyQ domains in both the simple polyQ and
httNTQ30P10K2 contexts and suggests that the characteristic
structural features shared by all of the labeled glutamines also
extend to the bulk of the polyQ domain.
Water Accessibility. As a picture arises in which the N-term-
inal helix is mobile and seemingly not incorporated into the
amyloid fibril proper, we explored the water exposure of different
parts of these fibrils via relaxation-filtered MAS NMR. This is an
approach previously applied to membrane proteins and amyloid
fibrils.38,39,52 Following a T2 relaxation filter to select the highly
mobile water protons, a 1H-1H diffusion period permits the
monitoring of magnetization transfer back into the more rigid
fibrils, observed as 13C signals following 1H-13C CP transfer.
The water-based origin of the 1H polarization was confirmed
using 2D 1H-13C spectra (not shown). The data on labeled
samples p2 and p3 (Figure 7) reveal that residues in the httNT
segment are polarized faster than either of the labeled glutamines.
It also appears that the Gln19 sites are less accessible than Gln18.
Even though a quantitative interpretation is not straightforward,
since various polarization transfer mechanisms can be active in
these experiments,53 it is clear that the N-terminal helix is more
accessible to water than either of the labeled glutamine residues.
’DISCUSSION
N-Terminal Helicity. The first target in our investigation was
the characterization of the conformation of the httNT segment in
the mature amyloid fibrils. This short peptide element appears to
initiate the aggregation mechanism of exon 1-like peptides, but
only when attached to a polyQ sequence of significant length.10
As a monomer in solution, the httNT segment by itself appears
to exist as an ensemble of compact states that transiently sample
R-helical conformations.10,16,25 While enhanced helicity and self-
association have been observed in certain contexts,10,54 whether
and how the structure of httNT changes as the aggregation
reaction initiates and proceeds has been unclear. The general
ability of the amyloid motif to recruit peptide segments into β-
structure suggests that the httNT segment might similarly be
drawn into the β-structure amyloid core as the polyQ domain
adopts it β-stranded amyloid conformation, and recently publis-
hed molecular dynamics simulations24 support this expectation.
Given the above context, our observations are of particular
interest and somewhat surprising, since our ssNMR data on the
ﬁbrils clearly reveal helicity in residues spanning positions 4-11,
which constitute an amphipathic helix (Figure 5b). HttNT as an
amphipathic helix had previously been proposed as a functional
unit, for instance, as a membrane-binding targeting motif.16,20
Amphipathicity and helicity have also been reported as essential
for the httNT-dependent enhancement of ﬁbrillization16,17 and to
aﬀect toxicity and nuclear accumulation.16 However, it has been
diﬃcult to obtain solid structural data to support the existence of
this R-helix in a biologically relevant setting. In this work, we
provide the ﬁrst direct experimental data demonstrating the
presence and precise location of the R-helical segment in the
context of the amyloid-like ﬁbrils. The observed helical segment
is bracketed by nonhelical residues, clearly showing that the
R-helix does not span the whole httNT, in contrast with earlier
X-ray data54 and simulation results.31 Instead, the observed
R-helical segment appears to match well to experimental CD
data suggesting 40-55% helical content10,16,25 and certain
simulations.17,31 Solution NMR experiments indicate that in
the isolated httNT the helicity may be transient, unstable, and
most pronounced in the N-terminal few residues.10
Our FTIR data show that self-aggregation of the httNT peptide
results in helical aggregates, suggesting that the helical structure
is stabilized upon oligomerization. Through interacting with each
other, the amphipathic httNT peptides may provide a much more
hydrophobic environment than the monomer experiences in
solution. This could signiﬁcantly increase the stability of the
helical conformation, in the oligomers and throughout the
aggregation process. A recent X-ray study on a fusion construct
consisting of a maltose-binding protein fused to the N-terminus
of htt exon 1 (featuring 17 Gln residues in its polyQ domain) also
revealed helicity in the httNT segment (and beyond).54 Interest-
ingly, the crystal contacts in these crystals included httNT-httNT
interactions in an httNT helical bundle, possibly analogous to the
types of interactions involved in the early aggregates. A picture
arises in which isolated, monomeric httNT has a limited propen-
sity to attain a partial helical structure, but that this propensity
may be modulated by interactions involving membranes, the
polyQ domain, other httNT molecules, or other proteins.
Glutamine Amyloid Core Structure. As expected, the FTIR
data show the presence of high β-sheet content in the K2Q31K2
and httNTQ30P10K2 fibrils. On the basis of NMR on the labeled
httNTQ30P10K2 fibrils, we also know that residues at the htt
NT-
polyQ boundary (including Gln18 and Gln19) are in a β-sheet
conformation. The observed rigidity and lack of water exposure
of the glutamines, which extend into the side chains, is consistent
with their being in a restricted and dehydrated polar-zipper- or
steric-zipper-like motif.55,56 Among the β-sheet residues at the
C-terminal end of the httNT domain, we do see that the Phe17
side chains experience substantial mobility (see Figure S3 in the
Figure 7. 13C-detected water-ﬁltered CP experiments on samples p2
(a) and p3 (b). The top row shows the 1H-13C CP signals in the
absence of a T2 ﬁlter. A water-proton-selective T2 ﬁlter eliminates
virtually all peptide signals (middle row). Seven millisecond 1H-1H
longitudinal mixing results in 1H polarization transfer from water into
the ﬁbrils (bottom). Gln18 and especially Gln19 signals remain sup-
pressed in the water-ﬁltered spectra (red arrows), whereas sites in the
httNT helix are easily polarized (e.g., Lys6 in sample p3).
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Supporting Information). However, such dynamics do not
necessarily require or imply solvent exposure of the Phe rings.57
Both the FTIR and NMR data fail to show any obvious
spectroscopic diﬀerences for the polyQ amyloid core of “simple”
polyQ ﬁbrils compared to that of httNTQ30P10K2 ﬁbrils. More
convincingly, we observed strikingly similar patterns of chemical
shifts for both Gln18 and Gln19 in httNTQ30P10K2 and for Gln6
in K2Q30K2. Our data also suggest that most of the glutamine
residues within the rigid polyQ core feature the same two
conformations that are present in these two site-speciﬁcally
labeled glutamines. It is thought that the ﬁbrillar polyQ should
incorporate tight turns connecting extended β-strands,51 and it
seems likely that the signals we observed reﬂect the residues that
would occupy the β-strands.
One intriguing feature of all the β-sheet residues is that they
present doubled sets of NMR resonances of roughly equivalent
intensity. Multiplicity in amyloid ﬁbril ssNMR signals is not
uncommon and correlates with a heterogeneity of the molecular
conformation within the sample. Polymorphism23 of the macro-
scopic ﬁbril structure is one potential source. There are several
reasons that argue against ﬁbril polymorphism in this particular
case. First, no sign of polymorphism has been detected by EM or
other methods. Second, we see no sign of doubling for the signals
of any of the helical residues, indicating that any polymorphism
would have to be restricted to the β-sheet residues without
having any consequences for the helical residues. Furthermore,
we observe essentially identical spectroscopic signatures
(including resonance doubling) for Gln residues in aggregates
of both simple polyQ and httNTQ30P10K2 peptides; given the
radically diﬀerent kinetics and mechanisms by which these two
types of polyQ-containing peptides aggregate,10,11 it is highly
unlikely that both peptides would independently grow into
identical mixtures of polymorphic structures. Similarly, the
relative intensity of the doubled peaks appears relatively invariant
between samples, whereas onemay expect more variation if these
reﬂected diﬀerent polymorphic aggregates, each forming accord-
ing to its own mechanism-based kinetics.
On the other hand, a 1:1 peak ratio would seem inherently
consistent with homogeneous samples of certain supramolecular
motifs. Since parallel, in-register β-sheet structures inherently
feature a single conformation and thus a single NMR signal for
each residue,56,58 it appears unlikely that the polyQ segment in the
httN-terminal fragment examinedhere exists in parallel, in-register
β-sheets in the amyloid ﬁbril. Other supramolecular assemblies
are characterized by diﬀerent numbers of resonances for each
residue.59 Thus, signal doubling might be due to a structural
inequivalence of identical residues within the ﬁbril assembly, as a
consequence of antiparallel and/or out-of-register arrangements.
An antiparallel assembly, as previously proposed on the basis of
X-ray diﬀraction studies of polyQ aggregates,26,27 could indeed
generate two distinct conformations for each residue, thus ex-
plaining the doubled resonances. Another alternate (but not
mutually exclusive) explanation could involve a systematic or
“random” register shift of diﬀerent peptides within the amyloid
core, combined with a basic structure where alternating (odd- vs
even-numbered) residues feature distinct side chain conforma-
tions. Such a patternmay be accommodated by the uniform polyQ
sequence, and the resulting out-of-register assembly could be
expected to feature distinct sets of shifts for each sequence position
(despite being quite uniform in its overall assembly).
Implications for the AggregationMechanism. In summary,
we have clearly demonstrated the precise location of a well-
defined R-helix within the mature fibrils and found evidence
suggesting the presence ofR-helical structure in httNT oligomeric
aggregates. In the fibrils, the N-terminal residues adopt a water-
exposed and somewhat mobile helix packed against the highly
rigid and dehydrated amyloid core formed by the glutamine
residues. This polyQ amyloid core seems highly repetitive in its
molecular structure and shows striking similarities to the simple
polyQ fibrils.
These observations complement previous experimental re-
sults on the earlier stages of ﬁbril formation by analogous poly-
peptides, which revealed an accelerated pathway that includes the
formation of at least one oligomeric intermediate initiated via
httNT interactions. Our FTIR data indicate a high level of R-
helicity to be formed upon self-aggregation of the httNT peptides.
The amphipathic helix that we identiﬁed in the mature ﬁbrils may
thus also be present upon the initial assembly of oligomeric
intermediates. While there had been indirect evidence of such an
amphipathic helix being involved,17 structural data presented
here explicitly reveal the existence of an R-helical httNT segment
in both httNT oligomers and ﬁbrils. These results argue against a
model where the polyQ threshold length triggers ﬁbril formation
by permitting httNT to attain a β-conformation.24
Helicity in the oligomeric intermediates involved in amyloid
formation is actually not unprecedented and has even been
suggested to play a direct role in their formation.60 However,
in such cases, including two papers published while this paper
was in review, maturation of the ﬁbrils leads to a conversion into
β-sheet structure.60-64 The coincidence of our data on httNT-
polyQ peptides with recently published data on the islet amyloid
polypeptide (IAPP) is, in fact, remarkable: monomeric IAPP
lacks a stable helix in isolation, helicity is present in the
oligomeric aggregates, which mature into β-stranded amyloid
ﬁbrils, and mutations designed to interfere with helix-helix
interactions can abolish amyloid formation.63 Highly similar
considerations were also reported for very short designed
peptides.64 Our data provide a striking variation on this emerging
theme, in which a helical element plays a critical role in the initial
steps of amyloid formation, but without taking on β-sheet
characteristics and without being incorporated into the amyloid
core of the end stage ﬁbrils.
An intriguing question is whether or how these observations
aﬀect the thinking about amyloid formation in a more general
sense. For instance, the principles that have been applied in the
design of computational models aimed at predicting amyloid
formation rates from primary sequence information currently
often reﬂect the compatibility of test sequences with a generic
amyloid structural motif.65,66 If there is indeed a critical role for
helical conformations as well as nonlocal interactions (involving
domains that never end up in an amyloid structure), then an
over-reliance on compatibility with the ﬁnal amyloid conforma-
tion may not fully capture the kinetics governing the formation
process. In htt exon 1 aggregation it seems quite clear that the
httNT segment provides an orders-of-magnitude boost in aggre-
gation kinetics, as well as a dramatic change in mechanism,10
while never itself engaging the cross-β amyloid motif. Naturally,
it remains to be seen whether the mechanism by which httNT
stimulates ﬁbril formation is a rare oddity or is a more common,
but diﬃcult to observe, phenomenon. Recent data on IAPP and
other proteins (see above) lend some support to the latter point
of view.
In terms of the mature amyloid core structure, the spectro-
scopic similarities between the polyQ domain within the htt
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N-terminal context and in the simple polyQ peptides indicate a
resemblance in molecular structure. Given that amyloid structure
can be very sensitive to the ﬁbrillization conditions and mechan-
ism, this would appear to imply that the polyQ β-sheet core in the
htt context might be formed along a pathway similar to that which
occurs in the “simple” polyQ systems. The role of httNT may be
mostly to bring the polyQ domains into close proximity, thus
increasing the local concentration and permitting the ﬁbril forma-
tion to start, without heavily modifying the resulting molecular
structure. Note that the (local) polyQ concentration is known to
have a large eﬀect on the aggregation kinetics.4,6,11 Thus, some of
the structural and mechanistic lessons gleaned from studies of
simple polyQ peptides may apply to features of htt fragments as
well. This applies, for instance, to the observation that our NMR
data show doubled chemical shifts speciﬁc to the β-sheet residues,
raising doubts about assumptions of a parallel in-register confor-
mation in the polyQ amyloid core.18,29 Rather, it is perhaps more
consistent with other arrangements such as those proposed on the
basis of experimental data from simple polyQ ﬁbrils.26,27 As
previously noted, unique supramolecular features may be facili-
tated by the uniform polyQ sequence, in contrast to amyloid ﬁbrils
with glutamine-rich, but more complex primary sequences.67
These considerations then lead to a schematic picture of the
aggregation process as illustrated in Figure 8. Key to this
proposed pathway is the distinction between the roles of the
N-terminal segment and the polyQ domain in the initiation
of aggregation and the subsequent (but structurally separate)
formation of amyloid structure and maturation into ﬁbrils. Once
an amyloid core has formed (i.e., is nucleated), it is likely that
continued growth of the ﬁbrils no longer relies on the httNT-
httNT interaction. From the NMR data it is nonetheless clear that
the httNT helical conformation is shared by all peptides through-
out the ﬁbrils. Various questions remain, such as the detailed
molecular structure of the amyloid core and the nature of
potential httNT interactions with itself, the polyQ domain, or
the polyPro PPII helix. Nonetheless, these new experimental data
have clearly delineated key features of the process in vitro, which
may well play similar roles in the aggregation process in vivo and
thus aﬀect the onset of the disease.
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